Holdings
35
Concentrated
Top 10 weight
56%
Concentration
Active share
-
Style
Equity
-
Asset allocation
Portfolio
4Sectors
17High-conviction bets
65%Top sector wt.
-Cash
Market-cap allocation
Large cap42%
Mid cap22%
Small cap32%
Asset allocation
Asset mix not available.
Top holdings
8.7%
8.7%
Cipla LimitedEQUITY
6.8%6.4%
6.3%
5.0%
4.5%
3.7%
3.0%
Ajanta Pharma LimitedEQUITY
2.8%2.8%
Aurobindo Pharma LimitedEQUITY
2.8%Global Health LimitedEQUITY
2.7%Shilpa Medicare LimitedEQUITY
2.4%2.2%
2.1%
2.0%
Pfizer LimitedEQUITY
1.9%Mankind Pharma LimitedEQUITY
1.9%Abbott India LimitedEQUITY
1.9%1.9%
1.8%
1.7%
Lupin LimitedEQUITY
1.6%1.5%
Orchid Pharma LimitedEQUITY
1.4%Sanofi India LimitedEQUITY
1.2%1.1%
1.1%
1.1%
Concord Biotech LimitedEQUITY
0.7%0.7%
Novartis India LimitedEQUITY
0.4%0.3%
Net Current AssetsCASH_EQUIVALENT
-0.3%AI Smart summary
Pros
- Balanced across the metrics we track.
Cons
- Concentrated in Pharmaceuticals & Biotechnology - watch sector risk.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in this category.
No peers found in this category.
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
64.7%
28.9%
2.4%
0.3%